Senior insider sale
CLO & Secretary at LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$218.3K
2K shares
What this filing means
REARDON ANDREW plans to sell 2K shares of LIGAND PHARMACEUTICALS INC valued at approximately $218.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/23/2025ACC: 0001950047-25-004546
Officer· CLO & Secretary
Since Mar 2026
2K
Shares to sell
$218.3K
Approx. market value
500.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Performance Shares
Not Applicable
2/14/2025
500.00Total acquired500.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/14/2025 | Performance Shares Not Applicable | 500.00 | — |
| Total | 500.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
500.00
Market value
$57.3K
6/10/2025
—Completed
Units to sell
1K
Market value
$104.0K
5/15/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
500.00
Market value
$57.0K
6/23/2025
Total
Units
2K
Value
$218.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/10/2025 | 500.00 | $57.3K | — | Completed |
5/15/2025 | 1K | $104.0K | — | Completed |
| Planned — Approximate Date | ||||
6/23/2025 | 500.00 | $57.0K | NASDAQ | Planned |
| Total | 2K | $218.3K | ||